COVID-19 genomic susceptibility: Definition of ACE2 variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP Guidance
View ORCID ProfileClaire L Shovlin, View ORCID ProfileMarcela P. Vizcaychipi
doi: https://doi.org/10.1101/2020.05.12.20098160
Claire L Shovlin
1NHLI Vascular Science, Imperial College London, UK
2Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
PhD FRCPMarcela P. Vizcaychipi
2Respiratory Medicine, Imperial College Healthcare NHS Trust, London UK
4Surgery and Cancer, Imperial College London, UK
MD PhDArticle usage
Posted May 19, 2020.
COVID-19 genomic susceptibility: Definition of ACE2 variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP Guidance
Claire L Shovlin, Marcela P. Vizcaychipi
medRxiv 2020.05.12.20098160; doi: https://doi.org/10.1101/2020.05.12.20098160
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)